Gene · 8929
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mining the Immunopeptidome for Antigenic Peptides in Cancer. | Cancers (Basel) | 2022 | 36291752 | PubTator, text mining | PubMed |
| Rapid and comprehensive diagnostic method for repeat expansion diseases using nanopore sequencing. | NPJ Genom Med | 2022 | 36289212 | PubTator, text mining | PubMed |
| Noninvasive ventilation via bilevel positive airway pressure improved sleep in a child with congenital central hypoventilation syndrome: A case report. | Clin Case Rep | 2022 | 36276908 | PubTator, text mining | PubMed |
| Minimal residual disease detected by droplet digital PCR in peripheral blood stem cell grafts has a prognostic impact on high-risk neuroblastoma patients. | Heliyon | 2022 | 36276741 | PubTator, text mining | PubMed |
| The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma. | Front Cell Dev Biol | 2022 | 36263020 | PubTator, text mining | PubMed |
| Novel Treatment of Ventilator Dyssynchrony From Central Alveolar Hypoventilation Syndrome Utilizing Scheduled 5-Hydroxytryptamine-3 Receptor Antagonist. | J Med Cases | 2022 | 36258708 | PubTator, text mining | PubMed |
| Loss of CASZ1 tumor suppressor linked to oncogenic subversion of neuroblastoma core regulatory circuitry. | Cell Death Dis | 2022 | 36243768 | PubTator, text mining | PubMed |
| bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma. | Front Oncol | 2022 | 36237324 | PubTator, text mining | PubMed |
| Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations. | Int J Mol Sci | 2022 | 36232538 | PubTator, text mining | PubMed |
| The Extracellular Matrix and Neuroblastoma Cell Communication-A Complex Interplay and Its Therapeutic Implications. | Cells | 2022 | 36231134 | PubTator, text mining | PubMed |
| Neurosensory development of the four brainstem-projecting sensory systems and their integration in the telencephalon. | Front Neural Circuits | 2022 | 36213204 | PubTator, text mining | PubMed |
| A Newborn Infant with Congenital Central Hypoventilation Syndrome and Pupillary Abnormalities: A Literature Review. | AJP Rep | 2022 | 36187199 | PubTator, text mining | PubMed |
| Chaperonin containing TCP-1 (CCT/TRiC) is a novel therapeutic and diagnostic target for neuroblastoma. | Front Oncol | 2022 | 36185250 | PubTator, text mining | PubMed |
| Modular derivation of diverse, regionally discrete human posterior CNS neurons enables discovery of transcriptomic patterns. | Sci Adv | 2022 | 36179024 | PubTator, text mining | PubMed |
| Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse. | Front Oncol | 2022 | 36176417 | PubTator, text mining | PubMed |
| Current progress in CAR-T cell therapy for tumor treatment. | Oncol Lett | 2022 | 36168313 | PubTator, text mining | PubMed |
| Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma. | Genes Dis | 2022 | 36157484 | PubTator, text mining | PubMed |
| Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells. | Front Cell Dev Biol | 2022 | 36147741 | PubTator, text mining | PubMed |
| Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation. | Diagnostics (Basel) | 2022 | 36140661 | PubTator, text mining | PubMed |
| Typical Enhancers, Super-Enhancers, and Cancers. | Cancers (Basel) | 2022 | 36139535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8929/papers?page=19